Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of E4 on QTc Interval in Healthy Postmenopausal Women
NCT04819906Phase 1Completed
- Sponsor
- Estetra SRL
- Start
- Mar 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of estetrol in menopause (12 arms), sponsored by Estetra SRL. Primary endpoint: Placebo-corrected change from baseline QTcF. Started Mar 2021; status: completed.
02
Drugs
estetrol
03
Conditions
menopause
Beyond the preview
Go deeper on NCT04819906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04819906.